ADAMAS PHARMACEUTICALS INC's ticker is and the CUSIP is 00548A906. A total of 3 filers reported holding ADAMAS PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $239,000 | -8.4% | 48,700 | -1.4% | 0.00% | – |
| Q2 2021 | $261,000 | +90.5% | 49,400 | +73.3% | 0.00% | – |
| Q1 2021 | $137,000 | +13600.0% | 28,500 | +9400.0% | 0.00% | – |
| Q4 2020 | $1,000 | -98.4% | 300 | -98.0% | 0.00% | – |
| Q3 2020 | $63,000 | +2000.0% | 15,300 | +1290.9% | 0.00% | – |
| Q2 2020 | $3,000 | 0.0% | 1,100 | -8.3% | 0.00% | – |
| Q1 2020 | $3,000 | -98.8% | 1,200 | -98.1% | 0.00% | -100.0% |
| Q4 2019 | $245,000 | +2127.3% | 64,700 | +2840.9% | 0.00% | – |
| Q3 2019 | $11,000 | -96.9% | 2,200 | -96.1% | 0.00% | -100.0% |
| Q2 2019 | $352,000 | +2.9% | 56,700 | +17.9% | 0.00% | -25.0% |
| Q1 2019 | $342,000 | +149.6% | 48,100 | +198.8% | 0.00% | +300.0% |
| Q4 2018 | $137,000 | -68.6% | 16,100 | -26.1% | 0.00% | -66.7% |
| Q3 2018 | $436,000 | -21.2% | 21,800 | +1.9% | 0.00% | -40.0% |
| Q2 2018 | $553,000 | -41.5% | 21,400 | -46.0% | 0.01% | -50.0% |
| Q1 2018 | $946,000 | -46.6% | 39,600 | -24.3% | 0.01% | -16.7% |
| Q4 2017 | $1,772,000 | +193.9% | 52,300 | +83.5% | 0.01% | +140.0% |
| Q3 2017 | $603,000 | +3447.1% | 28,500 | +2750.0% | 0.01% | – |
| Q2 2017 | $17,000 | – | 1,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GROUP ONE TRADING, L.P. | 300 | $1,000 | 0.00% |
| SIMPLEX TRADING, LLC | 12 | $5,000 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |